# Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer

> **NCT03010761** · PHASE2 · TERMINATED · sponsor: **China Medical University Hospital** · enrollment: 90 (actual)

## Conditions studied

- Addiction

## Interventions

- **DRUG:** escitalopram
- **DRUG:** Moclobemide
- **DRUG:** Placebo - Cap

## Key facts

- **NCT ID:** NCT03010761
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01-14
- **Primary completion:** 2018-01-31
- **Final completion:** 2018-01-31
- **Target enrollment:** 90 (ACTUAL)
- **Why stopped:** all participants finished the trial
- **Last updated:** 2019-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03010761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03010761, "Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03010761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*